034bf585-dba6-4c0b-9cac-2da10113397b

CertisOI Assistant generates charts and graphs to visualize data for greater insights. This is a scatter plot of PDX breast cancer models with negative expression of ERBB2 (HER2). The x-axis represents the model names, the y-axis represents the log2 fold change, and the color intensity represents the transcripts per million. Models with lower log2 fold change values have more negative expression.

Powered by Predictive Artificial Intelligence

Focused uniquely on cancer research, this one-of-a-kind chatbot is integrated with CertisAI™, a validated, patent-pending AI/ML platform that predicts therapeutic efficacy by identifying complex gene expression biomarkers that correlate with drug response.

This integration gives users no-charge access to many powerful features of CertisAI™, including efficacy predictions for FDA-approved drugs used in combination. 

Learn more about CertisAI™

Certis Oncology Intelligence®

Combining powerful predictive AI with advanced preclinical models to deliver clear and compelling evidence of therapeutic efficacy.


Generate Drug Response Predictions

View CertisOI™ Demo